Schuetz J D, Schuetz E G
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.
Cell Growth Differ. 1993 Jan;4(1):31-40.
Previous studies reported that, in the absence of drug exposure, multidrug resistance, including resistance to Adriamycin (ADR), could develop in primary rat hepatocyte cultures (B. Carr, Proc. Am. Assoc. Cancer Res., 29:1158, 1988). However, the hepatocytes in that report were cultured on plastic without the benefit of an extracellular matrix (ECM). Because the ECM regulates hepatic gene expression, we have critically evaluated in primary cultures of rat hepatocytes how the ECM affects hepatic ADR resistance, the level of the drug efflux transporter associated with MDR, P-glycoprotein (pgp), and transport of a prototypical pgp substrate, vincristine. Hepatocytes cultured on type I collagen (Vitrogen) had greater resistance to ADR toxicity accompanied by parallel increases in the level of pgp mRNA, decreased drug accumulation, and enhanced drug efflux when compared with the hepatocytes maintained on the basement membrane matrix Matrigel. The development of ADR resistance coincided with the time course of increased pgp mRNA but was not coincident with the time course of expression of either the placental isozyme of glutathione S-transferase or P-450 reductase, proteins associated with MDR in some resistance models. Southern blot analysis revealed neither gross changes in pgp gene structure or gene copy number to account for the increase in pgp RNA levels for hepatocytes cultured on Vitrogen. ECM also regulated xenobiotic-inducible expression of hepatic pgp, since chemotherapeutic agents, including vincristine and colchicine, induced pgp mRNA exclusively in hepatocytes cultured on Vitrogen. The critical matrix proteins in Matrigel responsible for regulation of pgp were determined by the selective addition of its components to the culture environment. The presentation of the individual matrix elements as a rigid substratum to the hepatocyte did not decrease pgp mRNA. In contrast, the presentation to the same hepatocytes of either laminin or type IV collagen in a nonrigid state (solubly in the medium) selectively decreased hepatocellular pgp mRNA. We conclude that primary rat hepatocytes develop ADR resistance with time in culture due to increased expression of pgp and that ECM proteins represent endogenous physiological modulators of both basal and chemotherapeutically inducible expression of hepatic P-glycoprotein.
先前的研究报道,在未接触药物的情况下,原代大鼠肝细胞培养物中可能会出现多药耐药性,包括对阿霉素(ADR)的耐药性(B. Carr,《美国癌症研究协会会刊》,29:1158,1988)。然而,该报告中的肝细胞是在塑料上培养的,没有细胞外基质(ECM)的益处。由于ECM调节肝脏基因表达,我们在原代大鼠肝细胞培养物中严格评估了ECM如何影响肝脏对ADR的耐药性、与多药耐药相关的药物外排转运蛋白P-糖蛋白(pgp)的水平以及典型pgp底物长春新碱的转运。与维持在基底膜基质基质胶上的肝细胞相比,在I型胶原蛋白(Vitrogen)上培养的肝细胞对ADR毒性具有更高的耐药性,同时pgp mRNA水平平行增加、药物积累减少且药物外排增强。ADR耐药性的发展与pgp mRNA增加的时间进程一致,但与谷胱甘肽S-转移酶胎盘同工酶或P-450还原酶(在某些耐药模型中与多药耐药相关的蛋白质)表达的时间进程不一致。Southern印迹分析显示,对于在Vitrogen上培养的肝细胞,pgp基因结构或基因拷贝数均无明显变化来解释pgp RNA水平的增加。ECM还调节肝脏pgp的外源性诱导表达,因为包括长春新碱和秋水仙碱在内的化疗药物仅在Vitrogen上培养的肝细胞中诱导pgp mRNA。通过将基质胶的成分选择性添加到培养环境中,确定了基质胶中负责调节pgp的关键基质蛋白。以刚性基质形式向肝细胞呈现单个基质成分不会降低pgp mRNA。相反,以非刚性状态(可溶于培养基)向相同肝细胞呈现层粘连蛋白或IV型胶原蛋白会选择性降低肝细胞pgp mRNA。我们得出结论,原代大鼠肝细胞在培养过程中会随着时间的推移因pgp表达增加而产生ADR耐药性,并且ECM蛋白是肝脏P-糖蛋白基础表达和化疗诱导表达的内源性生理调节因子。